Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lobe Sciences ( (TSE:LOBE) ) has issued an announcement.
Lobe Sciences has promoted Mirza Rahimani to Chief Financial Officer, effective March 2, 2026, after he had been providing financial advisory services to management and the board since December 2025. Rahimani replaces former CFO Yong Yao, who served through an arrangement with Century Biolabs Inc.
Rahimani brings more than 15 years of experience in accounting, financial reporting, corporate governance, and corporate development across life sciences, mining, and technology sectors. The company’s leadership highlights his track record in public-company compliance, strategic transactions and financings as a key asset to support Lobe’s growth plans and execution of its biopharmaceutical strategy.
The most recent analyst rating on (TSE:LOBE) stock is a Sell with a C$0.06 price target. To see the full list of analyst forecasts on Lobe Sciences stock, see the TSE:LOBE Stock Forecast page.
Spark’s Take on TSE:LOBE Stock
According to Spark, TipRanks’ AI Analyst, TSE:LOBE is a Neutral.
The score is constrained primarily by weak financial performance (no revenue, ongoing losses, and persistent cash burn), with only modest current leverage as a partial offset. Technicals add downside bias with the price below key moving averages and a negative MACD, while valuation provides limited support due to negative earnings and no dividend yield data.
To see Spark’s full report on TSE:LOBE stock, click here.
More about Lobe Sciences
Lobe Sciences Ltd. is a Canadian biopharmaceutical company focused on developing therapeutic programs for diseases with significant unmet medical needs. The company advances its pipeline through subsidiaries, including majority-owned Cynaptec Pharmaceuticals, Inc. and wholly owned Applied Lipid Technologies, Inc., and operates as a public issuer with listings in Canada, the U.S., and Frankfurt.
YTD Price Performance: 33.33%
Average Trading Volume: 66,640
Technical Sentiment Signal: Buy
Current Market Cap: C$16.17M
See more data about LOBE stock on TipRanks’ Stock Analysis page.